Human-tissue grafts · Regenerative medicine · Biomaterials
L&C BIO
A regenerative-medicine firm developing human-tissue grafts, supplying skin and cartilage implants and biomaterials for tissue repair. KOSDAQ large-cap constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.
Business categories Regenerative & Aesthetic Biomaterials · Biopharma & Life Sciences · primary Medical Devices & Supplies · Biopharma & Life Sciences
Other companies in the same category
- Regenerative & Aesthetic Biomaterials: Caregen · ROKIT Healthcare
- Medical Devices & Supplies: Olympus · Becton, Dickinson and Company · STERIS plc · West Pharmaceutical Services · ResMed Inc.
290650.KQ Updated Jul 11, 2026 2 AI consumers· 1 recurring
Annual return · 2026-10-08'21-12.7%'22-30.2%'23+7.9%'24-2.5%'25+301.2%YTD-38.8%
Money in ▸·
L&C BIO
▸ Money out·
Financials & Segments
- Segments · Human-tissue grafts · Biomaterials
Revenue from
No refined links yet.
Pays to
No refined links yet.